Welcome to our dedicated page for Cvs Health news (Ticker: CVS), a resource for investors and traders seeking the latest updates and insights on Cvs Health stock.
CVS Health Corporation operates an integrated health care model that combines retail pharmacy, pharmacy benefit management, health insurance, medical clinics, specialty and mail pharmacy support, and related consumer health services. Recurring company news includes quarterly results and guidance, segment performance across Health Services, Health Care Benefits, and Pharmacy & Consumer Wellness, and capital returns through common-stock dividends.
Updates also cover CVS Caremark formulary decisions, biosimilar adoption, Aetna prior authorization and plan-administration initiatives, community health investments by the CVS Health Foundation, and developments involving Omnicare, the company's long-term care pharmacy subsidiary.
CVS Health is set to administer COVID-19 vaccines starting February 11, 2021, at 28 pharmacy locations in Virginia. Approximately 26,000 doses will be available through the federal pharmacy partnership program. Appointments can be booked beginning February 9. This vaccine rollout is part of an initial plan covering 11 states, with CVS capable of administering 20-25 million shots monthly. CVS also advances vaccination efforts at over 870 long-term care facilities across Virginia, aiming for complete first doses by mid-February. The company highlights its community presence as key to effective vaccination.
CVS Health is set to begin administering COVID-19 vaccines at 32 pharmacy locations across New York starting February 11, 2021. Appointments can be booked from February 9, with a total supply of approximately 20,600 doses. The initiative is part of a broader 11-state rollout and aims to expand as vaccine supplies increase. CVS focuses on community presence for efficient vaccine distribution. The company is also vaccinating residents at over 1,200 long-term care facilities in New York, with first doses expected to be completed by mid-February.
CVS Health will begin administering COVID-19 vaccines on February 11 at four pharmacy locations in Rhode Island. Appointments can be booked starting February 9 with 3,400 doses available. This initiative is part of a broader rollout across 11 states and aims to leverage CVS's community presence for vaccine distribution. The company plans to expand as more doses become available, with a capacity to administer up to 25 million shots monthly. CVS is also vaccinating residents in over 200 long-term care facilities in Rhode Island.
CVS Health will begin administering COVID-19 vaccines at 70 pharmacy locations in Texas starting February 11, 2021. Approximately 38,000 doses will be available initially, with appointments open for booking on February 9. The rollout is part of an 11-state initiative, with plans to expand as vaccine supply increases. CVS aims to provide 20-25 million shots monthly nationwide, emphasizing community access to vaccines. Additionally, CVS is progressing with vaccination efforts in over 2,000 long-term care facilities in Texas, aiming to complete first doses by mid-February.
CVS Health is set to administer COVID-19 vaccines starting on February 11 at 18 locations in Massachusetts. This initiative is part of a broader rollout across 11 states, with approximately 21,600 doses available. Appointments for vaccinations can be booked from February 9. CVS aims to administer 20-25 million shots monthly as supply increases. The company is also vaccinating staff and residents at over 1,900 long-term care facilities in the state, with first doses expected to be completed by mid-February.
CVS Health will start administering COVID-19 vaccines at 27 pharmacy locations in New Jersey on February 11, 2021. Appointments can be booked from February 9, with approximately 19,900 doses available for the initial rollout. The company is part of a broader initiative to provide vaccines across 11 states, aiming to eventually administer 20-25 million shots per month. Vaccines will be offered to eligible individuals as per state guidelines, with a focus on safety and community presence.
CVS Health (NYSE: CVS) announced it will start administering COVID-19 vaccines at seven Longs Drugs locations in Hawaii from February 11, 2021. Approximately 4,400 doses will be available through the federal pharmacy partnership program. Appointments can be booked starting February 9. CVS plans to eventually offer vaccines across 335 locations in eleven states, aiming to administer 20-25 million vaccines monthly. CVS is also progressing in vaccinating residents at over 45 long-term care facilities in Hawaii.
CVS Health announced that starting February 11, it will administer COVID-19 vaccines at 18 locations in Maryland. This initiative is part of a broader rollout across 11 states, with an initial supply of approximately 11,000 doses. Appointments can be booked from February 9, and only eligible individuals who meet state criteria can receive vaccinations. CVS aims to expand its services as more vaccines become available, with a capacity to administer 20-25 million shots monthly. The company also continues vaccination efforts in over 1,700 long-term care facilities.
CVS Health will begin administering COVID-19 vaccines at 100 locations across California starting February 11, 2021. Approximately 81,900 doses will be available initially, with appointments open for booking on February 9. This effort is part of a broader rollout in 11 states, expanding CVS's capacity to deliver 20-25 million vaccinations monthly. The company also continues to vaccinate residents at over 15,000 long-term care facilities in California. CVS aims to make healthcare more accessible and affordable while addressing the ongoing pandemic.
CVS Health will start administering COVID-19 vaccines to eligible residents on February 11 at 12 pharmacy locations in Connecticut. The rollout will include approximately 6,800 doses sourced from a federal partnership program. Appointments can be booked from February 9. The initiative is part of a broader plan involving 335 locations across 11 states with a capacity to administer 20-25 million shots monthly. CVS is also vaccinating residents at over 570 long-term care facilities in Connecticut, aiming to finish first doses by mid-February.